Back

Noninvasive predictors of residual coronary microvascular dysfunction after elective percutaneous coronary intervention

31 August 2024 (07:55 - 08:50)
Organised by: Logo
Congress Presentation Part of: Risk stratification in percutaneous coronary intervention (1) Coronary Microcirculation and Collaterals ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Eisuke Usui

Tsuchiura Kyodo General Hospital, Tsuchiura (Japan)

8 More presentations in this session

Presentation thumbnail
A new hydration strategy can reduce contrast-induced acute kidney injury after PCI in patients with chronic heart failure and chronic kidney disease: a two-center randomized controlled trial
Professor K. Chen (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Prognostic outcome of ACS in HTX patients after PCI
Ms L. Elbinger (Bad Oeynhausen, DE)
Abstract Slides Video
Presentation thumbnail
The use of allopurinol in prophylaxis against contrast-induced nephropathy in patients undergoing percutaneous coronary intervention
Doctor K. Mahmoud (Cairo, EG)
Abstract Slides Video
Presentation thumbnail
Clinical impact of systemic inflammation across the spectrum of different high-sensitivity CRP values in patients undergoing percutaneous coronary intervention
Doctor A. Oliva (New York, US)
Abstract Slides Video
Presentation thumbnail
Gender differences in coronary artery disease patterns
Doctor D. Munhoz (Aalst, BE)
Abstract Slides Video

Access the full session

Session thumbnail
Risk stratification in percutaneous coronary intervention (1)

The Event

Event poster

ESC Congress 2024

31 August 2024 07:55 CET
You may be interested in
thumbnail
Congress Presentation
Residual Microvasuclar Dysfunction (RMVD) after percutaneous coronary intervention (PCI) assessed by stress- transthoracic Doppler echocardiography (S-TDE).
thumbnail
Congress Session
Microvascular dysfunction in stable coronary artery disease
thumbnail
Congress Presentation
Microvascular functional assessment using microvascular resistance reserve in patients undergoing elective fractional flow reserve-guided percutaneous coronary intervention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources